4//SEC Filing
DeLong Mark Jeffrey 4
Accession 0001127602-24-010605
CIK 0001492422other
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 4:03 PM ET
Size
4.3 KB
Accession
0001127602-24-010605
Insider Transaction Report
Form 4
DeLong Mark Jeffrey
Chief Business & Strat Officer
Transactions
- Sale
Common Stock
2024-03-18$56.90/sh−9,913$564,050→ 54,693 total
Documents
Issuer
Apellis Pharmaceuticals, Inc.
CIK 0001492422
Entity typeother
Related Parties
1- filerCIK 0001856078
Filing Metadata
- Form type
- 4
- Filed
- Mar 18, 8:00 PM ET
- Accepted
- Mar 19, 4:03 PM ET
- Size
- 4.3 KB